Source study found

Story checked

Noninvasive Cancer Treatment Looks Safe, yet 11% of Patients Died Within a Month (opens in a new tab)

scitechdaily.com · 2026-10-04

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

1 supported
4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Noninvasive Cancer Treatment Looks Safe, yet 11% of Patients Died Within a Month

scitechdaily.com · 2026-10-04

The story’s checkable claims.

Read the original story

NewsLink checks it

Mostly not supported

The one claim we could check holds up. One of five claims matches the study. This overall rating is based only on the claims we could check. Four claims the study doesn't address.

1 supported
4 not covered

Open claim evidence

The source study

Early Outcomes of Histotripsy for Liver Tumors in US Clinical Practice

JAMA Network Open · 2026Open access

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredThe study reported that 11% of patients died within 30 days.View evidenceHide evidence

As stated11% within 30 days

Why this verdict

The supplied abstract profile does not report mortality outcomes, a 30-day follow-up window, or an 11% death rate. Although the story frames this as an observed mortality proportion rather than a causal claim, the headline-prominent numerical claim cannot be verified from the abstract-level evidence.

Study evidence

The study evaluates short-term (early) clinical outcomes after histotripsy for liver tumors in US clinical practice among adult patients; specific outcome results are not reported in the available abstract excerpt.

Claim 2 of 5Not coveredHistotripsy is a noninvasive treatment that uses focused sound waves to destroy liver tumors and is typically performed on an outpatient basis.View evidenceHide evidence

Why this verdict

The abstract-level profile confirms that the paper concerns histotripsy for liver tumors in adult US clinical practice, but it does not state that histotripsy uses focused sound waves, destroys tumors, is noninvasive, or is typically outpatient. These may be true background facts, but they are not verifiable from the supplied abstract evidence.

Study evidence

The study evaluates national practice patterns and short-term outcomes of histotripsy for liver tumors among adult patients in US clinical practice.

Study evidence

Claim 3 of 5Not coveredThe researchers argue that choosing the right patients and the timing of histotripsy may be just as important as performing the treatment safely.View evidenceHide evidence

Why this verdict

The abstract-level profile says the study evaluated practice patterns, patient/tumor characteristics, and short-term outcomes, but it does not provide the authors' discussion or conclusions about patient selection, timing, or the comparative importance of selection versus procedural safety. The quoted interpretive claim is therefore not verifiable at this depth.

Study evidence

The study evaluates national practice patterns and short-term outcomes of histotripsy for liver tumors among adult patients in US clinical practice.

Study evidence

Claim 4 of 5Not coveredAmong 972 patients treated between 2023 and 2026, histotripsy was associated with low rates of laboratory toxicity and procedural complications.View evidenceHide evidence

As stated972 patients

Why this verdict

The profile supports that the paper evaluated short-term outcomes after histotripsy in a cohort, but the supplied abstract evidence contains no sample size, laboratory-toxicity rates, complication rates, or directionality. The stated 972-patient denominator and 'low rates' conclusion are therefore not verifiable at abstract depth.

Study evidence

Claim 5 of 5SupportedThe study could not determine whether histotripsy contributed to those deaths.View evidenceHide evidence

Why this verdict

The profile identifies the study as an observational cohort using clinical-practice data and explicitly notes that this design limits causal inference about effectiveness or safety. That supports the story's caveat that the study could not determine whether histotripsy caused or contributed to deaths, although the underlying death count/rate itself is not verifiable from the abstract.

Study evidence

The study evaluates national practice patterns and short-term outcomes of histotripsy for liver tumors among adult patients in US clinical practice.

Study evidence

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

A primary contribution is evaluation of national practice patterns, including utilization, patient/tumor characteristics, center patterns, and procedural patterns.
The story focuses on safety, mortality, and patient selection but does not clearly describe the paper's national practice-pattern contribution or its utilization/center/procedural-pattern emphasis.
From Observational cohort (secondary clinical practice data)
The supplied abstract profile does not provide quantitative outcome data, sample size, specific outcome definitions, or analytic details.
The story gives specific numbers and outcomes, including 972 patients, low toxicity/complication rates, and 11% 30-day mortality, but those details are absent from the supplied abstract-level paper evidence and cannot be checked at this depth.
From Observational cohort (secondary clinical practice data); cohort study
Longer-term safety or effectiveness outcomes are not reported in the supplied abstract evidence.
The story emphasizes early procedural safety and 30-day mortality but does not explicitly note that the abstract-level evidence only concerns short-term outcomes and does not establish longer-term safety or effectiveness.
From cohort study

3 things the story did carry across

The paper is a cohort study of adult patients treated with histotripsy for liver tumors in US clinical practice.
A primary contribution is evaluation of short-term or early clinical outcomes after histotripsy for liver tumors.
The observational cohort design limits causal inference and is vulnerable to selection and information biases.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEvaluate short-term (early) clinical outcomes after histotripsy for liver tumors in US clinical practice among adult patients.cohort studyExpand

In plain English

Cohort study reporting national practice patterns and short-term (early) clinical outcomes after histotripsy for liver tumors among adult patients in US clinical practice. The available excerpt (title and single-sentence abstract) states the study aim but does not provide outcome data, follow-up window, sample size, or analytic details.

Key findings

The study evaluates short-term (early) clinical outcomes after histotripsy for liver tumors in US clinical practice among adult patients; specific outcome results are not reported in the available abstract excerpt.

What this piece can’t prove

Summary is based only on title and a one-sentence abstract; no outcome data, sample size, follow-up window, or analytic methods were provided in the available excerpt.
Cannot determine specific outcomes measured (eg, adverse events, length of stay, imaging response) or their incidence/severity from the provided text.
Cannot assess adjustment for confounding, missing data handling, or other methodological details needed to evaluate internal validity.

2secondary dataEvaluate national practice patterns of histotripsy for liver tumors in US clinical practice among adult patients.Observational cohort (secondary clinical practice data)Expand

In plain English

Cohort study that evaluates national practice patterns and short-term outcomes of histotripsy for liver tumors among adult patients treated in US clinical practice. The abstract frames the work as a descriptive/observational analysis of utilization, patient and tumor characteristics, center/procedural patterns, and early outcomes, but does not provide quantitative results in the supplied text.

Key findings

The study evaluates national practice patterns and short-term outcomes of histotripsy for liver tumors among adult patients in US clinical practice.

What this piece can’t prove

Only the abstract text was provided; no quantitative results, follow-up durations, or sample size are available in the supplied evidence.
Study is observational (cohort) and uses clinical practice/secondary data, which may limit causal inference and be subject to selection and information biases.
The abstract references short-term outcomes; longer-term safety or effectiveness outcomes are not reported in the provided text.

Finally, the search trail

Method layer